MEDICAL devices developer Visiomed Group has secured the crucial regulatory clearance that paves the way for the commercialisation of its Funhaler asthma spacer into the lucrative US market.

MEDICAL devices developer Visiomed Group has secured the crucial regulatory clearance that paves the way for the commercialisation of its Funhaler asthma spacer into the lucrative US market.